z-logo
open-access-imgOpen Access
Risk factors of multidrug-resistant bacteria in community-acquired urinary tract infections
Author(s) -
Ertuğrul Güçlü,
Fikret Halis,
Elif Odabaş Köse,
Aziz Öğütlü,
Oğuz Karabay
Publication year - 2021
Publication title -
african health sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.391
H-Index - 44
eISSN - 1729-0503
pISSN - 1680-6905
DOI - 10.4314/ahs.v21i1.28
Subject(s) - medicine , urinary system , antibiotics , incidence (geometry) , bacteria , multiple drug resistance , antibiotic resistance , pediatrics , microbiology and biotechnology , biology , physics , genetics , optics
Background Urinary tract infections (UTIs) are one of the most seen infection among community. Objectives In this cross-sectional study we aimed to investigate the risk factors of multidrug-resistant (MDR) bacteria that caused community-acquired UTI (CA-UTI). Methods Consecutive patients admitted to the Urology and Infectious Diseases policlinics with the diagnosis of CA-UTI were included in the study. A standard form including possible predisposing factors for MDR bacteria was applied. Results In total, 240 patients (51.3% females) were enrolled in the study. The mean age of participants were 59.8 ± 18.3 years old. Escherichia coli (n =166; 69.2%)was the most frequently isolated bacteria and its incidence was higher in females than in males (p=0.01). In total, 129 (53.8%) of the identified pathogens were MDR bacteria. According to multivariate analysis, the use of antibiotics three or more times increased the risk of infection with MDR bacteria by 4.6 times, the history of urinary tract infection in the last 6 months by 2 times, being male and over 65 years old by 3 times. Conclusion Doctors should consider prescribing broad-spectrum antibiotics in patients with severe UTIs with a history of UTI, advanced age, male gender, and multiple antibiotic usage, even if they have a CA-UTI.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here